TR200101903T2 - Yeni malonik asit türevleri, bunların preparasyon işlemleri. - Google Patents

Yeni malonik asit türevleri, bunların preparasyon işlemleri.

Info

Publication number
TR200101903T2
TR200101903T2 TR2001/01903T TR200101903T TR200101903T2 TR 200101903 T2 TR200101903 T2 TR 200101903T2 TR 2001/01903 T TR2001/01903 T TR 2001/01903T TR 200101903 T TR200101903 T TR 200101903T TR 200101903 T2 TR200101903 T2 TR 200101903T2
Authority
TR
Turkey
Prior art keywords
compounds
formula
acid derivatives
malonic acid
prevention
Prior art date
Application number
TR2001/01903T
Other languages
English (en)
Inventor
Defossa Elisabeth
Heinelt Uwe
Klingler Otmar
Zoller Gerhard
Matter Hans
A. Al-Obeidi Fahad
Walser Armin
Wildgoose Peter
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99100002A external-priority patent/EP1016663A1/en
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200101903T2 publication Critical patent/TR200101903T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Abstract

Mevcut bulus, kan pihtilastirma proteinlerinin önlenmesine yönelik yeni bilesiklerle ve daha özel olarak R(1), R(2), R(3), R(4), R(5) ve R(6)'nin istemlerden belirtilen anlamlara geldigi formül (I)'e ait malonik asit türevleriyle ilgilidir. Formül (I)'e ait bilesikler, kan pihtilastirici enzim faktör Xa'nin önleyicileridir. Bulus, formül (I)'e ait bilesiklerin preparasyon islemleriyle, faktör Xa aktivitesinin önlenmesine ve kan pihtilasmasinin önlenmesine yönelik metotlar, tromboembolik hastaliklar gibi faktör Xa aktivitesinin önlenmesiyle tedavi edilebilen veya engellenebilen hastaliklarin tedavisinde ve profilaksisinde formül (I)'e ait bilesiklerin kullanilmasiyla, ve formül (I)'e ait bilesiklerin, bu hastaliklarda uygulanabilecek ilaçlarin preparasyonunda kullanilmasiyla da ilgilidir
TR2001/01903T 1999-01-02 1999-12-23 Yeni malonik asit türevleri, bunların preparasyon işlemleri. TR200101903T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99100002A EP1016663A1 (en) 1999-01-02 1999-01-02 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
EP99119537 1999-10-01

Publications (1)

Publication Number Publication Date
TR200101903T2 true TR200101903T2 (tr) 2001-11-21

Family

ID=26152843

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01903T TR200101903T2 (tr) 1999-01-02 1999-12-23 Yeni malonik asit türevleri, bunların preparasyon işlemleri.

Country Status (17)

Country Link
US (1) US6395737B1 (tr)
EP (1) EP1140878A1 (tr)
JP (1) JP2002534420A (tr)
KR (1) KR20010101355A (tr)
CN (1) CN1332734A (tr)
AU (1) AU3043100A (tr)
BR (1) BR9916732A (tr)
CA (1) CA2358578A1 (tr)
CZ (1) CZ20012379A3 (tr)
HK (1) HK1041700A1 (tr)
HU (1) HUP0105437A3 (tr)
ID (1) ID29979A (tr)
IL (1) IL144096A0 (tr)
NO (1) NO20012983D0 (tr)
PL (1) PL349343A1 (tr)
TR (1) TR200101903T2 (tr)
WO (1) WO2000040571A1 (tr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239478T3 (es) 1999-01-02 2005-09-16 Aventis Pharma Deutschland Gmbh Derivados de arilalcanoilo, procedimientos para su preparacion, su uso y composiciones farmaceuticas que los contienen.
EP1127884A1 (en) * 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
JP4744149B2 (ja) 2002-12-03 2011-08-10 ファーマサイクリックス インコーポレイテッド 第ｖｉｉａ因子阻害剤としての２−（２−ヒドロキシビフェニル−３−イル）−１ｈ−ベンゾイミダゾール−５−カルボキサミジン誘導体
US9279022B1 (en) 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
CN105949358A (zh) 2010-10-20 2016-09-21 瑟拉斯公司 基本不含杂质的亚甲基丙二酸酯的合成
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
EP2899183B1 (en) 2011-10-14 2018-09-19 Bristol-Myers Squibb Company Substituted Tetrahydroisoquinoline Compounds as Factor Xia Inhibitors
IN2014CN02805A (tr) 2011-10-14 2015-07-03 Bristol Myers Squibb Co
AR088456A1 (es) 2011-10-14 2014-06-11 Bristol Myers Squibb Co Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia
CA2853079A1 (en) 2011-10-19 2013-05-10 Bioformix Inc. Methylene beta-ketoester monomers, methods for making methylene beta-ketoester monomers, polymerizable compositions and products formed therefrom
EP3848402A1 (en) 2012-03-30 2021-07-14 Sirrus, Inc. Ink and coating formulations and polymerizable systems for producing the same
WO2013149165A1 (en) 2012-03-30 2013-10-03 Bioformix Inc. Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby
EP3153530B1 (en) 2012-03-30 2021-02-24 Sirrus, Inc. Composite and laminate articles and polymerizable systems for producing the same
WO2013181600A2 (en) 2012-06-01 2013-12-05 Bioformix Inc. Optical material and articles formed therefrom
EP2906541B1 (en) 2012-10-12 2017-11-22 Bristol-Myers Squibb Company Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
US9920034B2 (en) 2012-10-12 2018-03-20 Bristol-Myers Squibb Company Crystalline forms of a factor XIa inhibitor
WO2014059202A1 (en) 2012-10-12 2014-04-17 Bristol-Myers Squibb Company Guanidine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
EP2920231B1 (en) 2012-11-16 2020-05-06 Sirrus, Inc. Plastics bonding systems and methods
CN105164797B (zh) 2012-11-30 2019-04-19 瑟拉斯公司 用于电子应用的复合组合物
EP2943462B1 (en) 2013-01-11 2018-06-27 Sirrus, Inc. Method to obtain methylene malonate via bis(hydroxymethyl) malonate pathway
WO2014160668A1 (en) 2013-03-25 2014-10-02 Bristol-Myers Squibb Company Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
NO2760821T3 (tr) 2014-01-31 2018-03-10
US9777001B2 (en) 2014-01-31 2017-10-03 Bristol-Myers Squibb Company Macrocycles with aromatic P2′ groups as factor xia inhibitors
EP3164406A4 (en) 2014-07-01 2018-04-04 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
JP6526796B2 (ja) 2014-09-04 2019-06-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｆｘｉａ阻害剤であるジアミドマクロ環
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE242404C (tr)
DE235866C (tr)
US4504492A (en) * 1981-09-25 1985-03-12 Burroughs Wellcome Co. Pharmaceutical amides, and preparation, formulations and use thereof
EP0511347A1 (de) 1990-11-15 1992-11-04 Pentapharm A.G. Meta-substituierte phenylalanin-derivate
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.
JPH07509731A (ja) 1993-02-10 1995-10-26 ペンタファルム　アクチェンゲゼルシャフト トロンビン阻害剤としての置換されたフェニルアラニン誘導体のピペラジド
US5977074A (en) * 1993-10-01 1999-11-02 Merrell Pharmaceuticals, Inc. Inhibitors of β-amyloid protein production
EP0758341B1 (en) * 1994-04-26 2004-03-24 Aventis Pharmaceuticals, Inc. FACTOR Xa INHIBITORS
AU3107795A (en) * 1994-08-09 1996-03-07 Pentapharm Ag Inhibitors of the benzamidine type
GB9420763D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
CZ295362B6 (cs) * 1995-12-20 2005-07-13 Aventis Pharmaceuticals Inc. Způsob přípravy N-acetyl-(L)-4-kyanofenylalaninu Ac-(L)-Phe(4-CN)-OH a N-acetyl-(L)-p-amidinofenylalanincyklohexylglycin-beta-(3-N-methylpyridinium)-alaninu Ac-(L)-pAph-Chg-PalMe(3)-NH2
PT979240E (pt) 1997-05-02 2004-08-31 Akzo Nobel Nv Inibidores de serina-protease
SI1042287T1 (en) 1997-12-24 2005-10-31 Aventis Pharma Deutschland Gmbh Indole derivatives as inhibitors of factor xa
EP1016663A1 (en) 1999-01-02 2000-07-05 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)

Also Published As

Publication number Publication date
AU3043100A (en) 2000-07-24
JP2002534420A (ja) 2002-10-15
ID29979A (id) 2001-10-25
KR20010101355A (ko) 2001-11-14
BR9916732A (pt) 2001-09-25
NO20012983L (no) 2001-06-15
CA2358578A1 (en) 2000-07-13
CZ20012379A3 (cs) 2001-09-12
IL144096A0 (en) 2002-05-23
EP1140878A1 (en) 2001-10-10
NO20012983D0 (no) 2001-06-15
HK1041700A1 (zh) 2002-07-19
HUP0105437A3 (en) 2003-03-28
WO2000040571A1 (en) 2000-07-13
PL349343A1 (en) 2002-07-15
CN1332734A (zh) 2002-01-23
HUP0105437A2 (hu) 2002-05-29
US6395737B1 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
TR200101903T2 (tr) Yeni malonik asit türevleri, bunların preparasyon işlemleri.
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
TR200001954T2 (tr) Faktör XA'nın önleyicileri olarak indol türevleri.
BR0011130A (pt) Inibidores de metaloproteases
ATE242003T1 (de) Enzyme zur behandlung von diabetes mellitus typ i
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
MEP43008A (en) Indole-2-carboxamides as factor xa inhibitors
NO20002958L (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
WO2004033455A3 (en) Hemisuccinate salts of heterocyclic dpp-iv inhibitors
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
HK1120794A1 (en) Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
TR200103550T2 (tr) Faktör VIIa inhibitörler.
TR200201181T2 (tr) N-ganidinoalkilamidler, hazırlanmaları,kullanımları ve bunları içeren farmasötik preparatlar
TR200101980T2 (tr) Arilalkanoil türevleri, bunların preparasyon işlemleri
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
ATE361914T1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
MXPA05007715A (es) Derivados de carboxamida y uso de los mismos como inhibidores del factor xa.